China Shineway Pharmaceutical Group Limited (HKG:2877)
Hong Kong
· Delayed Price · Currency is HKD 9.85
+0.07 (0.72%)
Apr 29, 2026, 4:08 PM HKT
HKG:2877 Revenue
In the year 2025, China Shineway Pharmaceutical Group had annual revenue of 3.14B CNY, down -17.01%. China Shineway Pharmaceutical Group had revenue of 1.48B in the half year ending December 31, 2025, a decrease of -29.99%.
Revenue
3.14B CNY
Revenue Growth
-17.01%
P/S Ratio
2.12
Revenue / Employee
1.09M CNY
Employees
2,867
Market Cap
7.39B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.14B | -642.62M | -17.01% |
| Dec 31, 2024 | 3.78B | -738.50M | -16.35% |
| Dec 31, 2023 | 4.52B | 565.90M | 14.32% |
| Dec 31, 2022 | 3.95B | 727.09M | 22.56% |
| Dec 31, 2021 | 3.22B | 567.85M | 21.38% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical | 763.16M |
| SSY Group | 4.17B |
| Edding Genor Group Holdings | 2.77B |
| China Traditional Chinese Medicine Holdings Co. | 16.41B |
| Beijing Tong Ren Tang Chinese Medicine Company | 1.51B |
| Shandong Xinhua Pharmaceutical Company | 9.74B |
| Luye Pharma Group | 7.02B |
| Ab&B Bio-Tech CO., LTD. JS | 354.77M |